Blackstone Life Sciences Announces $455 Million Collaboration to Co-Fund Development of Boston Scientific VITALYST™ Heart Pump for Patients with Cardiogenic Shock
Key Highlights
- ➤$455 million collaboration co-funds Boston Scientific’s VITALYST heart-pump development
- ➤VITALYST targets acute myocardial infarction cardiogenic shock, a life-threatening emergency
- ➤VITALYST is designed to increase cardiac output and improve blood flow to vital organs
- ➤Collaboration marks Boston Scientific and Blackstone Life Sciences’ first joint product-development funding
Expert Statements
Nicholas Galakatos, Global Head of Blackstone Life Sciences
“Boston Scientific has built a leading cardiovascular franchise, with deep expertise in developing and commercializing transformative technologies for patients and physicians.”
Nicholas Galakatos, Global Head of Blackstone Life Sciences
“We believe the VITALYST system has the potential to improve on the efficacy and safety of currently available mechanical circulatory support technologies, and this collaboration reflects our ability to help leaders in innovation bring important new medical devices to patients.”
Blackstone Life Sciences Announces $455 Million Collaboration to Co-Fund Development of Boston Scientific VITALYST™ Heart Pump for Patients with Cardiogenic Shock
Blackstone Life Sciences (“BXLS”) today announced a $455 million collaboration with Boston Scientific Corporation (NYSE: BSX) to co-fund the development of the VITALYST™ Temporary Percutaneous Transvalvular Circulatory Support System program. The VITALYST system is a next-generation, miniature heart pump intended to increase cardiac output and improve blood flow from the heart to the brain and other vital organs. It is designed to treat acute myocardial infarction cardiogenic shock (AMI-CS), a life-threatening medical emergency where the heart cannot pump enough blood to supply the brain and other organs with oxygen. This is the first time that Boston Scientific and BXLS will co-fund the development of a Boston Scientific product.
Get started
Create a free account to read the full story.